Related Experiment Video
Updated: Apr 21, 2026

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
Published on: March 5, 2022
Cytokines in acute chikungunya
Anuradha Venugopalan1, Ravi P Ghorpade1, Arvind Chopra1
1Center for Rheumatic Diseases, Pune, India.
Introduction:
Acute chikungunya (CHIKV) is predominantly an acute onset of excruciatingly painful, self-limiting musculoskeletal (MSK) arbovirus illness and this was further reported by us during the 2006 Indian epidemic [Chopra et al. Epidemiol Infect 2012]. Selected serum cytokines profile in subjects within one month of onset of illness is being presented.
Methods:
Out of 509 clinical CHIKV cases (43% population) identified during a rural population survey, 225 subjects consented blood investigations. 132 examined within 30 days of febrile onset are the study cohort. Anti-CHIKV IgM and IgG antibodies tested by immunochromatography and indirect immunofluorescence respectively. Interferons (IFN)-α, -β and -γ, Interferon Gamma-Induced Protein-10 (CXCL-10/IP-10), Tumor Necrosis Factor-α (TNF-α), Interleukin-1β (IL-1β), Interleukin-6 (IL-6), Interleukin-13 (IL-13), Monocyte Chemoattractant Protein-1 (MCP-1), Interleukin-4 (IL-4) and Interleukin-10 (IL-10) performed by ELISA. Samples collected from neighboring community a year prior to the epidemic used as healthy controls.
Results:
Seropositivity for anti-CHIKV IgM and IgG was 65% and 52% respectively. IFN-α, IFN-β, IFN-γ, CXCL10/IP-10 and IL-1β showed intense response in early acute phase. Cytokines (particularly TNF-α, MCP-1, IL-4, IL-6 and IL-10) was maximum in extended symptomatic phase and remained elevated in recovered subjects. Higher (p<0.05) IFN and IL-4 seen in patients seropositive for anti-CHIKV IgG. Elderly cases (≥65 years) showed elevated cytokines (except IFN) and anti-CHIKV antibodies near similar to younger subjects. Significant correlations (p<0.05) found between cytokines and clinical features (fatigue, low back ache, myalgia) and anti-CHIKV antibodies.
Conclusion:
An intense cytokine milieu was evident in the early and immediate persistent symptomatic phase and in recovered subjects. Early persistent IgM and lower IgG to anti-CHKV and intense Th2 cytokine phenotype seem to be associated with delay in resolution of MSK symptoms. Intriguingly, maximum TNF-α, IL-6 and IL-13 with low anti-CHIKV IgM response found in subjects recovered from CHIKV within one month of illness.
Insights
Chikungunya virus (CHIKV) infection triggers intense immune responses, with specific cytokines linked to symptom duration and severity. Understanding these cytokine profiles aids in managing musculoskeletal pain and recovery.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Chikungunya (CHIKV) is a painful arbovirus illness causing musculoskeletal symptoms.
- Previous studies, including a 2006 Indian epidemic, have documented CHIKV's impact.
- This study presents serum cytokine profiles in CHIKV patients within one month of illness onset.
Purpose of the Study:
- To analyze serum cytokine profiles in acute chikungunya patients.
- To correlate cytokine levels with clinical features and antibody responses.
- To investigate factors influencing symptom resolution in CHIKV infection.
Main Methods:
- Analyzed serum cytokines (IFN-α, -β, -γ, CXCL-10, TNF-α, IL-1β, IL-6, IL-13, MCP-1, IL-4, IL-10) using ELISA in 132 CHIKV patients.
- Tested for anti-CHIKV IgM and IgG antibodies via immunochromatography and immunofluorescence.
- Included healthy controls from a prior community survey.
Main Results:
- Elevated levels of IFN-α, IFN-β, IFN-γ, CXCL-10, and IL-1β were observed in the early acute phase.
- Cytokines like TNF-α, MCP-1, IL-4, IL-6, and IL-10 peaked in the extended symptomatic phase and remained high post-recovery.
- Higher Interferon (IFN) and Interleukin-4 (IL-4) levels correlated with anti-CHIKV IgG seropositivity; elderly patients showed similar cytokine profiles to younger ones.
Conclusions:
- An intense cytokine response is characteristic of acute and persistent CHIKV infection, extending into the recovery phase.
- Delayed musculoskeletal symptom resolution is associated with early persistent IgM, lower IgG anti-CHIKV antibodies, and a Th2 cytokine phenotype.
- Specific cytokine patterns, including high TNF-α, IL-6, IL-13 with low IgM, were noted in patients recovering within one month.
Related Concept Videos
Acute Inflammation I: Cellular Phase
Arboviral Encephalitis
Acute Inflammation II: Local and Systemic Effects
Acute Inflammation I: Inflammatory Response
Cytotoxic Edema: Pathophysiology
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

